Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Long-term persistence of humoral immunity after hepatitis A vaccination in HIV-infected adults.

Kernéis S, Desaint C, Brichler S, Rey D, Belarbi L, Gordien E, Pacanowski J, Lortholary O, Abgrall S, Boëlle PY, Grabar S, Launay O.

J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):e63-6. doi: 10.1097/QAI.0b013e31821fdec3. No abstract available.

PMID:
21860353
2.

Predictors of immunity after hepatitis A vaccination in HIV-infected persons.

Overton ET, Nurutdinova D, Sungkanuparph S, Seyfried W, Groger RK, Powderly WG.

J Viral Hepat. 2007 Mar;14(3):189-93.

PMID:
17305885
3.

Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults.

Crum-Cianflone NF, Wilkins K, Lee AW, Grosso A, Landrum ML, Weintrob A, Ganesan A, Maguire J, Klopfer S, Brandt C, Bradley WP, Wallace MR, Agan BK; Infectious Disease Clinical Research Program HIV Working Group.

J Infect Dis. 2011 Jun 15;203(12):1815-23. doi: 10.1093/infdis/jir180.

4.

Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects.

Wallace MR, Brandt CJ, Earhart KC, Kuter BJ, Grosso AD, Lakkis H, Tasker SA.

Clin Infect Dis. 2004 Oct 15;39(8):1207-13. Epub 2004 Sep 24.

PMID:
15486846
5.

Vaccination against viral hepatitis of HIV-1 infected patients.

Phung BC, Launay O.

Hum Vaccin Immunother. 2012 May;8(5):554-9. doi: 10.4161/hv.19105. Epub 2012 May 1. Review.

PMID:
22634451
6.

Responses to hepatitis A virus vaccine in HIV-infected women: effect of hormonal contraceptives and HIV disease characteristics.

Weinberg A, Allshouse AA, Mawhinney S, Canniff J, Benning L, Wentz EL, Minkoff H, Young M, Nowicki M, Greenblatt R, Cohen MH, Golub ET.

J Acquir Immune Defic Syndr. 2012 May 1;60(1):e15-8. doi: 10.1097/QAI.0b013e31824d30bd. No abstract available.

7.

Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial.

Kemper CA, Haubrich R, Frank I, Dubin G, Buscarino C, McCutchan JA, Deresinski SC; California Collaborative Treatment Group.

J Infect Dis. 2003 Apr 15;187(8):1327-31. Epub 2003 Mar 24.

PMID:
12696015
8.

Hepatitis A and B vaccination practices for ambulatory patients infected with HIV.

Tedaldi EM, Baker RK, Moorman AC, Wood KC, Fuhrer J, McCabe RE, Holmberg SD; HIV Outpatient Study (HOPS) Investigators.

Clin Infect Dis. 2004 May 15;38(10):1478-84. Epub 2004 Apr 28.

PMID:
15156488
9.

Antibody response to hepatitis A immunization among human immunodeficiency virus-infected children and adolescents.

Siberry GK, Coller RJ, Henkle E, Kiefner C, Joyner M, Rogers J, Chang J, Hutton N.

Pediatr Infect Dis J. 2008 May;27(5):465-8. doi: 10.1097/INF.0b013e31816454a3.

PMID:
18382387
10.

Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.

Van Damme P, Leroux-Roels G, Law B, Diaz-Mitoma F, Desombere I, Collard F, Tornieporth N, Van Herck K.

J Med Virol. 2001 Sep;65(1):6-13.

PMID:
11505437
11.

Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART.

Belaunzarán-Zamudio PF, García-León ML, Wong-Chew RM, Villasís-Keever A, Cuellar-Rodríguez J, Mosqueda-Gómez JL, Muñoz-Trejo T, Escobedo K, Santos JI, Ruiz-Palacios GM, Sierra-Madero JG.

Vaccine. 2009 Nov 23;27(50):7059-64. doi: 10.1016/j.vaccine.2009.09.063. Epub 2009 Sep 30.

PMID:
19799846
12.

Hepatitis A and B virus immunization in HIV-infected persons.

Laurence J.

AIDS Read. 2006 Jan;16(1):15-7. Review. No abstract available.

PMID:
16433468
13.

[Hepatitis A vaccine].

Fujiyama S.

Nihon Rinsho. 2005 May;63 Suppl 5:631-7. Review. Japanese. No abstract available.

PMID:
15954421
14.
15.

Effects of highly active antiretroviral therapy on vaccine-induced humoral immunity in HIV-infected adults.

González R, Castro P, García F, Plana M, Bayas JM, Lafuente S, Serrano B, Mora B, Argelich R, Gatell JM, Vilella A.

HIV Med. 2010 Sep;11(8):535-9. doi: 10.1111/j.1468-1293.2010.00830.x. Epub 2010 Apr 13.

16.

Hepatitis A vaccines.

Shahidah KN.

Med J Malaysia. 2005 Jul;60 Suppl B:112-5. Review.

PMID:
16108190
17.

Routine vaccination of HIV-infected patients against hepatitis A: should we discriminate before vaccination according to ethnicity?

Górgolas M, Rivas P, Guerrero ML.

Clin Infect Dis. 2005 Jul 15;41(2):272-3. No abstract available.

PMID:
15983933
18.

[Efficacy of vaccination against hepatitis A in HIV infected adults from Lodz region--preliminary report].

Jabłonowska E, Kuydowicz J, Małolepsza E.

Przegl Epidemiol. 2008;62(3):605-12. Polish.

PMID:
19108525
19.

Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults.

Hammitt LL, Bulkow L, Hennessy TW, Zanis C, Snowball M, Williams JL, Bell BP, McMahon BJ.

J Infect Dis. 2008 Dec 15;198(12):1776-82. doi: 10.1086/593335.

PMID:
18976095
20.

[Response to hepatitis A and hepatitis B vaccination: genetic differences].

Degos F.

Gastroenterol Clin Biol. 2003 Apr;27(4):429-30. French. No abstract available.

Supplemental Content

Support Center